USH3A
MCID: USH038
MIFTS: 43

Usher Syndrome, Type Iiia (USH3A)

Categories: Ear diseases, Eye diseases, Fetal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Usher Syndrome, Type Iiia

MalaCards integrated aliases for Usher Syndrome, Type Iiia:

Name: Usher Syndrome, Type Iiia 58
Usher Syndrome, Type 3a 58 30 13 6 41
Ush3 58 12 54 60 76
Usher Syndrome Type 3 12 60 76 15
Ush3a 58 12 54 76
Usher Syndrome, Type Iii 58 41 74
Usher Syndrome Type 3a 12 54 15
Usher Syndrome, Type Iii; Ush3 58
Usher Syndrome Type Iiia 12
Usher's Syndrome Type 3 76
Usher Syndrome Type Iii 76
Usher Syndrome, Type 3 77
Usher Syndrome Iii 76
Usher Syndrome 3a 76

Characteristics:

Orphanet epidemiological data:

60
usher syndrome type 3
Inheritance: Autosomal recessive; Age of onset: Adolescent,Childhood;

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
increased frequency in finland
ush3 cases account for 40% of all usher patients in finland


HPO:

33
usher syndrome, type iiia:
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Usher Syndrome, Type Iiia

NIH Rare Diseases : 54 Usher syndrome is a genetic disorder characterized by sensorineural hearing loss or deafness and progressive vision loss due to retinitis pigmentosa. Sensorineural hearing means it is caused by abnormalities of the inner ear. Retinitis pigmentosa is an eye disease that affects the layer of light-sensitive tissue at the back of the eye (the retina). Vision loss occurs as the light-sensing cells of the retina gradually deteriorate. Night vision loss begins first, followed by blind spots that develop in the side (peripheral) vision, that can enlarge and merge to produce tunnel vision (loss of all peripheral vision). In some cases, vision is further impaired by clouding of the lens of the eye (cataracts). Three major types of Usher syndrome have been described - types I, II, and III. The different types are distinguished by their severity and the age when signs and symptoms appear. All three types are inherited in an autosomal recessive manner. Treatment for the hearing loss may include hearing aids or surgery for a cochlear implant. Vitamin A palmitate is useful for treating the vision loss in people with Usher syndrome type II.

MalaCards based summary : Usher Syndrome, Type Iiia, also known as usher syndrome, type 3a, is related to usher syndrome, type iia and usher syndrome, type ic. An important gene associated with Usher Syndrome, Type Iiia is CLRN1 (Clarin 1). Affiliated tissues include retina and eye, and related phenotypes are sensorineural hearing impairment and abnormal electroretinogram

Disease Ontology : 12 An Usher syndrome characterized by progressive hearing loss typically beginning in late childhood, variable vestibular dysfunction and onset of retinitis pigmentosa by the second decade of life.

OMIM : 58 Usher syndrome type III is characterized by postlingual, progressive hearing loss, variable vestibular dysfunction, and onset of retinitis pigmentosa symptoms, including nyctalopia, constriction of the visual fields, and loss of central visual acuity, usually by the second decade of life (Karjalainen et al., 1985; Pakarinen et al., 1995). For a discussion of phenotypic heterogeneity of Usher syndrome, see USH1 (276900). (276902)

UniProtKB/Swiss-Prot : 76 Usher syndrome 3A: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH3 is characterized by postlingual, progressive hearing loss, variable vestibular dysfunction, and onset of retinitis pigmentosa symptoms, including nyctalopia, constriction of the visual fields, and loss of central visual acuity, usually by the second decade of life.

Wikipedia : 77 Usher syndrome, also known as Hallgren syndrome, Usher–Hallgren syndrome, retinitis pigmentosa–dysacusis... more...

Related Diseases for Usher Syndrome, Type Iiia

Diseases in the Usher Syndrome family:

Usher Syndrome, Type I Usher Syndrome, Type Iia
Usher Syndrome, Type Iiia Usher Syndrome, Type Ic
Usher Syndrome, Type Id Usher Syndrome, Type if
Usher Syndrome, Type Iic Usher Syndrome, Type Ig
Usher Syndrome, Type Iid Usher Syndrome, Type Ih
Usher Syndrome, Type Iiib Usher Syndrome, Type Ij
Usher Syndrome, Type Ik Usher Syndrome, Type Iv
Usher Syndrome Type 2 Usher Syndrome, Type 2b

Diseases related to Usher Syndrome, Type Iiia via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 39)
# Related Disease Score Top Affiliating Genes
1 usher syndrome, type iia 31.6 USH1C USH2A
2 usher syndrome, type ic 31.2 CDH23 CLRN1 MYO7A USH1C
3 usher syndrome, type ig 30.7 CDH23 MYO7A PCDH15 USH1G
4 usher syndrome, type if 30.4 CDH23 MYO7A PCDH15 USH1C USH1G
5 usher syndrome, type id 29.6 ADGRV1 CDH23 MYO7A PCDH15 USH1C USH1G
6 usher syndrome, type i 29.4 ADGRV1 CDH23 CLRN1 MYO7A PCDH15 USH1C
7 usher syndrome, type iid 29.4 ADGRV1 CDH23 MYO7A PCDH15 USH1C USH1G
8 retinitis pigmentosa-deafness syndrome 28.8 ADGRV1 CDH23 MT-TS2 MYO7A PCDH15 USH2A
9 usher syndrome, type iic 28.7 ADGRV1 CDH23 CLRN1 MYO7A PCDH15 SLC4A7
10 usher syndrome 27.1 ADGRV1 CDH23 CEP78 CLRN1 HARS MYO7A
11 usher syndrome, type iiib 11.2
12 usher syndrome, type ij 11.1
13 usher syndrome, type ih 11.0
14 usher syndrome, type ik 11.0
15 nonsyndromic retinitis pigmentosa 10.2 CLRN1 USH2A
16 yemenite deaf-blind hypopigmentation syndrome 10.1 MYO7A USH2A
17 deafness, autosomal recessive 10.1 PCDH15 USH1C
18 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
19 dfnb1 10.1 MYO7A PCDH15
20 deafness, autosomal dominant 13 10.0 MYO7A USH2A
21 deafness, autosomal dominant 20 10.0 USH1C USH1G
22 deafness, autosomal recessive 85 10.0 CDH23 MYO7A
23 deafness, autosomal recessive 83 10.0 CDH23 MYO7A
24 autosomal recessive nonsyndromic deafness 3 10.0 CDH23 MYO7A
25 retinal disease 9.9
26 deafness, autosomal dominant 6 9.9 CDH23 MYO7A
27 inner ear disease 9.8 CDH23 MYO7A
28 deafness, autosomal recessive 23 9.8 CDH23 MYO7A PCDH15
29 deafness, autosomal recessive 12 9.7 CDH23 MYO7A PCDH15
30 deafness, autosomal recessive 6 9.7 ADGRV1 MYO7A USH2A
31 deafness, autosomal recessive 4, with enlarged vestibular aqueduct 9.7 CDH23 MYO7A
32 branchiootic syndrome 1 9.6 CDH23 MYO7A USH1G USH2A
33 auditory system disease 9.5 CDH23 MYO7A PCDH15 USH1C
34 bardet-biedl syndrome 9.5 CDH23 MYO7A PCDH15 USH1C
35 sensorineural hearing loss 9.4 CDH23 CEP78 MYO7A PCDH15 USH2A
36 autosomal recessive non-syndromic sensorineural deafness type dfnb 9.3 CDH23 MYO7A PCDH15 USH1C USH1G
37 nonsyndromic deafness 8.6 ADGRV1 CDH23 MYO7A PCDH15 USH1C USH1G
38 retinitis pigmentosa 8.1 ADGRV1 CDH23 CEP78 CLRN1 HARS MYO7A
39 usher syndrome type 2 8.0 ADGRV1 CDH23 CLRN1 HARS MYO7A PCDH15

Graphical network of the top 20 diseases related to Usher Syndrome, Type Iiia:



Diseases related to Usher Syndrome, Type Iiia

Symptoms & Phenotypes for Usher Syndrome, Type Iiia

Human phenotypes related to Usher Syndrome, Type Iiia:

60 33 (show all 24)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 sensorineural hearing impairment 60 33 frequent (33%) Very frequent (99-80%) HP:0000407
2 abnormal electroretinogram 60 33 hallmark (90%) Very frequent (99-80%) HP:0000512
3 nyctalopia 60 33 hallmark (90%) Very frequent (99-80%) HP:0000662
4 visual loss 60 33 hallmark (90%) Very frequent (99-80%) HP:0000572
5 iris hypopigmentation 60 33 hallmark (90%) Very frequent (99-80%) HP:0007730
6 scotoma 60 33 hallmark (90%) Very frequent (99-80%) HP:0000575
7 vestibular hypofunction 60 33 hallmark (90%) Very frequent (99-80%) HP:0001756
8 hemianopia 33 hallmark (90%) HP:0012377
9 abnormal cochlea morphology 33 hallmark (90%) HP:0000375
10 ataxia 60 33 frequent (33%) Frequent (79-30%) HP:0001251
11 cataract 60 33 frequent (33%) Frequent (79-30%) HP:0000518
12 astigmatism 60 33 frequent (33%) Frequent (79-30%) HP:0000483
13 visual field defect 33 frequent (33%) HP:0001123
14 vestibular dysfunction 33 frequent (33%) HP:0001751
15 high hypermetropia 33 frequent (33%) HP:0008499
16 depressivity 60 33 occasional (7.5%) Occasional (29-5%) HP:0000716
17 hallucinations 60 33 occasional (7.5%) Occasional (29-5%) HP:0000738
18 anxiety 60 33 occasional (7.5%) Occasional (29-5%) HP:0000739
19 schizophrenia 60 33 occasional (7.5%) Occasional (29-5%) HP:0100753
20 reduced visual acuity 33 HP:0007663
21 hemianopsia 60 Very frequent (99-80%)
22 high-grade hypermetropia 60 Frequent (79-30%)
23 abnormality of cochlea 60 Very frequent (99-80%)
24 rod-cone dystrophy 33 HP:0000510

Symptoms via clinical synopsis from OMIM:

58
Head And Neck Nose:
nyctalopia
retinitis pigmentosa
progressive restriction of visual feilds
reduction of central visual acuity

Head And Neck Eyes:
hearing loss, sensorineural, progressive post-lingual
vestibular dysfunction, variable

Clinical features from OMIM:

276902

MGI Mouse Phenotypes related to Usher Syndrome, Type Iiia:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 hearing/vestibular/ear MP:0005377 9.85 ADGRV1 CDH23 CLRN1 HARS MYO7A PCDH15
2 behavior/neurological MP:0005386 9.8 ADGRV1 CDH23 CLRN1 MYO7A PCDH15 USH1C
3 nervous system MP:0003631 9.61 ADGRV1 CDH23 CLRN1 MYO7A PCDH15 SLC4A7
4 vision/eye MP:0005391 9.28 ADGRV1 CDH23 CLRN1 MYO7A PCDH15 SLC4A7

Drugs & Therapeutics for Usher Syndrome, Type Iiia

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa Active, not recruiting NCT01530659 Phase 2 NT-501

Search NIH Clinical Center for Usher Syndrome, Type Iiia

Genetic Tests for Usher Syndrome, Type Iiia

Genetic tests related to Usher Syndrome, Type Iiia:

# Genetic test Affiliating Genes
1 Usher Syndrome, Type 3a 30 CLRN1

Anatomical Context for Usher Syndrome, Type Iiia

MalaCards organs/tissues related to Usher Syndrome, Type Iiia:

42
Retina, Eye

Publications for Usher Syndrome, Type Iiia

Articles related to Usher Syndrome, Type Iiia:

# Title Authors Year
1
The cone-dominant retina and the inner ear of zebrafish express the ortholog of CLRN1, the causative gene of human Usher syndrome type 3A. ( 24045267 )
2013

Variations for Usher Syndrome, Type Iiia

UniProtKB/Swiss-Prot genetic disease variations for Usher Syndrome, Type Iiia:

76
# Symbol AA change Variation ID SNP ID
1 CLRN1 p.Met120Lys VAR_012241 rs121908141
2 CLRN1 p.Asn48Lys VAR_030345 rs111033258
3 CLRN1 p.Leu150Pro VAR_030346 rs121908142
4 CLRN1 p.Cys40Gly VAR_054555 rs121908143
5 CLRN1 p.Ser105Pro VAR_054556
6 CLRN1 p.Ile168Asn VAR_071434

ClinVar genetic disease variations for Usher Syndrome, Type Iiia:

6 (show top 50) (show all 82)
# Gene Variation Type Significance SNP ID Assembly Location
1 CLRN1 NM_174878.2(CLRN1): c.502dupA (p.Ile168Asnfs) duplication Likely pathogenic rs746523071 GRCh37 Chromosome 3, 150645920: 150645920
2 CLRN1 NM_174878.2(CLRN1): c.502dupA (p.Ile168Asnfs) duplication Likely pathogenic rs746523071 GRCh38 Chromosome 3, 150928133: 150928133
3 CLRN1 NM_174878.2(CLRN1): c.149_152delCAGGinsTGTCCAAT (p.Ser50Leufs) indel Pathogenic/Likely pathogenic rs786204428 GRCh37 Chromosome 3, 150690344: 150690347
4 CLRN1 NM_174878.2(CLRN1): c.149_152delCAGGinsTGTCCAAT (p.Ser50Leufs) indel Pathogenic/Likely pathogenic rs786204428 GRCh38 Chromosome 3, 150972557: 150972560
5 CLRN1 NM_001195794.1(CLRN1): c.567T> G (p.Tyr189Ter) single nucleotide variant Pathogenic rs121908140 GRCh37 Chromosome 3, 150645894: 150645894
6 CLRN1 NM_001195794.1(CLRN1): c.567T> G (p.Tyr189Ter) single nucleotide variant Pathogenic rs121908140 GRCh38 Chromosome 3, 150928107: 150928107
7 CLRN1 NM_001195794.1(CLRN1): c.359T> A (p.Met120Lys) single nucleotide variant Pathogenic rs121908141 GRCh37 Chromosome 3, 150659443: 150659443
8 CLRN1 NM_001195794.1(CLRN1): c.359T> A (p.Met120Lys) single nucleotide variant Pathogenic rs121908141 GRCh38 Chromosome 3, 150941656: 150941656
9 CLRN1 NM_174878.2(CLRN1): c.459_461delATT (p.Ile153_Leu154delinsMet) deletion Pathogenic rs1085307049 GRCh37 Chromosome 3, 150645961: 150645963
10 CLRN1 NM_174878.2(CLRN1): c.459_461delATT (p.Ile153_Leu154delinsMet) deletion Pathogenic rs1085307049 GRCh38 Chromosome 3, 150928174: 150928176
11 CLRN1 NM_001195794.1(CLRN1): c.144T> G (p.Asn48Lys) single nucleotide variant Conflicting interpretations of pathogenicity rs111033258 GRCh37 Chromosome 3, 150690352: 150690352
12 CLRN1 NM_001195794.1(CLRN1): c.144T> G (p.Asn48Lys) single nucleotide variant Conflicting interpretations of pathogenicity rs111033258 GRCh38 Chromosome 3, 150972565: 150972565
13 CLRN1 NM_001195794.1(CLRN1): c.488T> C (p.Leu163Pro) single nucleotide variant Pathogenic rs121908142 GRCh37 Chromosome 3, 150645973: 150645973
14 CLRN1 NM_001195794.1(CLRN1): c.488T> C (p.Leu163Pro) single nucleotide variant Pathogenic rs121908142 GRCh38 Chromosome 3, 150928186: 150928186
15 CLRN1 NM_001195794.1(CLRN1): c.189C> A (p.Tyr63Ter) single nucleotide variant Pathogenic rs111033267 GRCh37 Chromosome 3, 150690307: 150690307
16 CLRN1 NM_001195794.1(CLRN1): c.189C> A (p.Tyr63Ter) single nucleotide variant Pathogenic rs111033267 GRCh38 Chromosome 3, 150972520: 150972520
17 CLRN1 NM_001195794.1(CLRN1): c.188_210del23 (p.Tyr63Cysfs) deletion Pathogenic rs1553776036 GRCh37 Chromosome 3, 150690286: 150690308
18 CLRN1 NM_001195794.1(CLRN1): c.188_210del23 (p.Tyr63Cysfs) deletion Pathogenic rs1553776036 GRCh38 Chromosome 3, 150972499: 150972521
19 CLRN1 NM_174878.2(CLRN1): c.118T> G (p.Cys40Gly) single nucleotide variant Conflicting interpretations of pathogenicity rs121908143 GRCh37 Chromosome 3, 150690378: 150690378
20 CLRN1 NM_174878.2(CLRN1): c.118T> G (p.Cys40Gly) single nucleotide variant Conflicting interpretations of pathogenicity rs121908143 GRCh38 Chromosome 3, 150972591: 150972591
21 CLRN1 NM_001195794.1(CLRN1): c.127G> A (p.Gly43Arg) single nucleotide variant Likely pathogenic rs111033434 GRCh37 Chromosome 3, 150690369: 150690369
22 CLRN1 NM_001195794.1(CLRN1): c.127G> A (p.Gly43Arg) single nucleotide variant Likely pathogenic rs111033434 GRCh38 Chromosome 3, 150972582: 150972582
23 CLRN1 NM_174878.2(CLRN1): c.301_305delGTCAT (p.Val101Serfs) deletion Pathogenic/Likely pathogenic rs397517932 GRCh37 Chromosome 3, 150659497: 150659501
24 CLRN1 NM_174878.2(CLRN1): c.301_305delGTCAT (p.Val101Serfs) deletion Pathogenic/Likely pathogenic rs397517932 GRCh38 Chromosome 3, 150941710: 150941714
25 CLRN1 NM_174878.2(CLRN1): c.368C> A (p.Ala123Asp) single nucleotide variant Pathogenic/Likely pathogenic rs374963432 GRCh37 Chromosome 3, 150659434: 150659434
26 CLRN1 NM_174878.2(CLRN1): c.368C> A (p.Ala123Asp) single nucleotide variant Pathogenic/Likely pathogenic rs374963432 GRCh38 Chromosome 3, 150941647: 150941647
27 CLRN1 NM_001195794.1(CLRN1): c.6A> C (p.Pro2=) single nucleotide variant Benign/Likely benign rs111033422 GRCh37 Chromosome 3, 150690490: 150690490
28 CLRN1 NM_001195794.1(CLRN1): c.6A> C (p.Pro2=) single nucleotide variant Benign/Likely benign rs111033422 GRCh38 Chromosome 3, 150972703: 150972703
29 CLRN1 NM_174878.2(CLRN1): c.433+1061A> T single nucleotide variant Uncertain significance rs567709615 GRCh38 Chromosome 3, 150940521: 150940521
30 CLRN1 NM_174878.2(CLRN1): c.433+1061A> T single nucleotide variant Uncertain significance rs567709615 GRCh37 Chromosome 3, 150658308: 150658308
31 CLRN1 NM_174878.2(CLRN1): c.619C> T (p.Arg207Ter) single nucleotide variant Pathogenic rs373208120 GRCh38 Chromosome 3, 150928016: 150928016
32 CLRN1 NM_174878.2(CLRN1): c.619C> T (p.Arg207Ter) single nucleotide variant Pathogenic rs373208120 GRCh37 Chromosome 3, 150645803: 150645803
33 CLRN1 NM_174878.2(CLRN1): c.433+2dupT duplication Likely pathogenic rs1057516687 GRCh37 Chromosome 3, 150659367: 150659367
34 CLRN1 NM_174878.2(CLRN1): c.433+2dupT duplication Likely pathogenic rs1057516687 GRCh38 Chromosome 3, 150941580: 150941580
35 CLRN1 NM_174878.2(CLRN1): c.13C> T (p.Gln5Ter) single nucleotide variant Likely pathogenic rs1057517224 GRCh38 Chromosome 3, 150972696: 150972696
36 CLRN1 NM_174878.2(CLRN1): c.13C> T (p.Gln5Ter) single nucleotide variant Likely pathogenic rs1057517224 GRCh37 Chromosome 3, 150690483: 150690483
37 CLRN1 NM_174878.2(CLRN1): c.218A> G (p.Gln73Arg) single nucleotide variant Uncertain significance rs201008540 GRCh37 Chromosome 3, 150690278: 150690278
38 CLRN1 NM_174878.2(CLRN1): c.218A> G (p.Gln73Arg) single nucleotide variant Uncertain significance rs201008540 GRCh38 Chromosome 3, 150972491: 150972491
39 CLRN1 NM_174878.2(CLRN1): c.541C> T (p.Gln181Ter) single nucleotide variant Likely pathogenic rs376155416 GRCh37 Chromosome 3, 150645881: 150645881
40 CLRN1 NM_174878.2(CLRN1): c.541C> T (p.Gln181Ter) single nucleotide variant Likely pathogenic rs376155416 GRCh38 Chromosome 3, 150928094: 150928094
41 CLRN1 NM_174878.2(CLRN1): c.407G> A (p.Gly136Glu) single nucleotide variant Uncertain significance rs779258184 GRCh37 Chromosome 3, 150659395: 150659395
42 CLRN1 NM_174878.2(CLRN1): c.407G> A (p.Gly136Glu) single nucleotide variant Uncertain significance rs779258184 GRCh38 Chromosome 3, 150941608: 150941608
43 CLRN1 NM_174878.2(CLRN1): c.291C> T (p.Ile97=) single nucleotide variant Uncertain significance rs1231233910 GRCh37 Chromosome 3, 150659511: 150659511
44 CLRN1 NM_174878.2(CLRN1): c.291C> T (p.Ile97=) single nucleotide variant Uncertain significance rs1231233910 GRCh38 Chromosome 3, 150941724: 150941724
45 CLRN1 NM_174878.2(CLRN1): c.254-2115delT deletion Uncertain significance rs1032160668 GRCh37 Chromosome 3, 150661662: 150661663
46 CLRN1 NM_174878.2(CLRN1): c.254-2115delT deletion Uncertain significance rs1032160668 GRCh38 Chromosome 3, 150943876: 150943876
47 CLRN1 NM_174878.2(CLRN1): c.151_154delGGGC (p.Gly51Argfs) deletion Likely pathogenic rs1553776061 GRCh37 Chromosome 3, 150690341: 150690345
48 CLRN1 NM_174878.2(CLRN1): c.151_154delGGGC (p.Gly51Argfs) deletion Likely pathogenic rs1553776061 GRCh38 Chromosome 3, 150972555: 150972558
49 CLRN1 NM_174878.2(CLRN1): c.40G> T (p.Gly14Ter) single nucleotide variant Likely pathogenic rs1553776112 GRCh37 Chromosome 3, 150690456: 150690456
50 CLRN1 NM_174878.2(CLRN1): c.40G> T (p.Gly14Ter) single nucleotide variant Likely pathogenic rs1553776112 GRCh38 Chromosome 3, 150972669: 150972669

Expression for Usher Syndrome, Type Iiia

Search GEO for disease gene expression data for Usher Syndrome, Type Iiia.

Pathways for Usher Syndrome, Type Iiia

GO Terms for Usher Syndrome, Type Iiia

Cellular components related to Usher Syndrome, Type Iiia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 synapse GO:0045202 9.83 ADGRV1 MYO7A PCDH15 SLC4A7 USH1C
2 apical plasma membrane GO:0016324 9.65 MYO7A SLC4A7 USH2A
3 ciliary basal body GO:0036064 9.63 CEP78 USH1G USH2A
4 microvillus GO:0005902 9.58 CLRN1 MYO7A USH1C
5 photoreceptor outer segment GO:0001750 9.54 MYO7A PCDH15 USH1C
6 photoreceptor inner segment GO:0001917 9.46 MYO7A USH1C USH1G USH2A
7 stereocilia ankle link GO:0002141 9.32 USH1C USH2A
8 stereocilia ankle link complex GO:0002142 9.26 USH1C USH2A
9 photoreceptor connecting cilium GO:0032391 9.26 MYO7A USH1C USH1G USH2A
10 stereocilium GO:0032420 9.17 ADGRV1 CDH23 CLRN1 MYO7A PCDH15 SLC4A7

Biological processes related to Usher Syndrome, Type Iiia according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 sensory perception of sound GO:0007605 9.86 ADGRV1 CDH23 CLRN1 MYO7A PCDH15 USH1C
2 visual perception GO:0007601 9.85 ADGRV1 CDH23 CLRN1 MYO7A PCDH15 USH2A
3 response to stimulus GO:0050896 9.83 ADGRV1 CDH23 CLRN1 USH2A
4 sensory perception of light stimulus GO:0050953 9.76 ADGRV1 CDH23 CLRN1 MYO7A PCDH15 USH1C
5 inner ear receptor cell stereocilium organization GO:0060122 9.72 CDH23 MYO7A PCDH15 USH1C USH1G
6 inner ear morphogenesis GO:0042472 9.67 MYO7A USH1C USH1G
7 auditory receptor cell stereocilium organization GO:0060088 9.63 CLRN1 MYO7A PCDH15
8 inner ear auditory receptor cell differentiation GO:0042491 9.61 MYO7A PCDH15 USH1C
9 inner ear receptor cell differentiation GO:0060113 9.58 MYO7A USH1G USH2A
10 inner ear development GO:0048839 9.54 MYO7A PCDH15
11 auditory receptor cell development GO:0060117 9.51 CLRN1 SLC4A7
12 photoreceptor cell maintenance GO:0045494 9.5 ADGRV1 CDH23 CLRN1 PCDH15 USH1C USH1G
13 maintenance of animal organ identity GO:0048496 9.48 ADGRV1 USH2A
14 equilibrioception GO:0050957 9.1 CDH23 CLRN1 MYO7A PCDH15 USH1C USH1G

Molecular functions related to Usher Syndrome, Type Iiia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 spectrin binding GO:0030507 8.8 MYO7A USH1C USH1G

Sources for Usher Syndrome, Type Iiia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....